Abstract
It has long been recognized that the growth and differentiation of resting mature T lymphocytes into functional helper or cytolytic cells is dependent upon not only an antigenic stimulus but also soluble factors (Plate, 1976; Ryser et al., 1978). Consequently, recent attention has been focused upon the identification and further characterization of these soluble regulators. Following the description of interleukin-2 (IL-2) as a T-cell growth factor that can influence the generation of cytolytic T lymphocytes (CTL) (Gillis et al., 1978), it became apparent that several other cytokines exist which have similar activity. However, many of the early studies on T cell-active factors were clouded by the use of impure cytokine preparations and the possibility of indirect effects occurring in bulk lymphocyte cultures due to cytokine cascades. Thus, it was possible that a reputed T-cell growth factor or CTL induction factor was in fact affecting the secondary production of IL-2 or other T-cell growth factors, rather than itself directly stimulating T cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alderson MR, Sassenfeld HM, Widmer MB (1990): Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J Exp Med 172: 577–587
Aoki T, Kikuchi H, Miyatake S, Oda Y, Iwasaki K, Yamasaki T, Kinashi T, Honjo T (1989): Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity. J Exp Med 170: 583–588
Armitage RJ, Namen AE, Sassenfeld HM, Grabstein KH (1990): Regulation of human T-cell proliferation by interleukin 7. J Immunol 144: 938–941
Borst J, van de Griend RJ, van Oostveen JW, Ang S, Melief CJ, Seidman JG, Bolhuis RLH (1987): A T-cell receptor y/CD3 complex found on cloned functional lymphocytes. Nature 325: 683–688
Chantry D, Turner M, Feldmann M (1989): Interleukin 7 (murine pre-B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: Regulation by transforming growth factor beta. Eur J Immunol 19: 783–786
Chazen GD, Pereira GMB, LeGros G, Gillis S, Shevach EM (1989): Interleukin 7 is a T-cell growth factor. Proc Natl Acad Sci USA 86: 5923–5927
Chen L-K, Tourvieille B, Burns GF, Bach FH, MathieuMahul D, Sasportes M, Bensussan A (1986): Interferon: A cytotoxic T lymphocyte differentiation signal. Eur J Immunol 16: 767–770
Chen W-F, Zlotnick A (1991): IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 147: 528–534
Conlon PJ, Morrissey PJ, Nordan RP, Grabstein KH, Prickett KS, Reed SG, Goodwin R, Cosman D, Namen AE (1989): Murine thymocytes proliferate in direct response to interleukin-7. Blood 74: 1368–1373
Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI (1989): Induction of human lymphokine-activated killer cells by IFN-a and IFN-y. J Immunol 143: 4282–4286
Fanslow WC, Clifford KN, Park LS, Rubin AS, Voice RF, Beckmann MP, Widmer MB (1991): Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 147: 535–540
Fanslow WC, Sims JE, Sassenfeld H, Morrissey PJ, Gillis S, Dower SK, Widmer MB (1990): Regulation of allo-reactivity in vivo by a soluble form of the interleukin-1 receptor. Science 248: 739–742
Fernandez-Botran R, Krammer PH, Diamantstein T, Uhr JW, Vitetta ES (1986): B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. J Exp Med 164: 580–593
Gillis S, Ferm MM, Ou W, Smith KA (1978): T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120: 2027–2032
Gillis S, Gillis AE, Henney CS (1981): Monoclonal antibody directed against interleukin-2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J Exp Med 154: 983–988
Grabstein KH, Park LS, Morrissey PJ, Sassenfeld H, Price V, Urdal DL, Widmer MB (1987): Regulation of murine T cell proliferation by B cell stimulatory factor-1. J Immunol 139: 1148–1153
Grabstein KH, Namen AE, Shanebeck K, Voice RF, Reed SG, Widmer MB (1990): Regulation of T cell proliferation by IL-7. J Immunol 144: 3015–3020
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982): Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823–1841
Hickman CJ, Crim JA, Mostowski HS, Siegal JP (1990): Regulation of human cytotoxic T lymphocyte development by IL-7. J Immunol 145: 2415–2420
Hu-Li J, Shevach EM, Mizuguchi J, Ohara J, Mosmann T, Paul WE (1987): B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J Exp Med 165: 157–172
Kaieda T, Okada M, Yoshimura N, Kishimoto S, Yamamura Y, Kishimoto T (1982): A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s). J Immunol 129: 46–51
Kawakami Y, Custer MC, Rosenberg SA, Lotze MT (1989): IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J Immunol 142: 3452–3461
Kern DE, Gillis S, Okada M, Henney CS (1981): The role of interleukin-2 (IL-2) in the differentiation of cytotoxic T cells: The effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. J Immunol 127: 1323–1328
Koide J, Rivas A, Engleman EG (1989): Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-7,6+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. J Immunol 142: 4161–4168
Lindqvist C, Nihlmark EL, Nordstrom T, Andersson LC (1991): Interleukin-4 downregulates the p70 chain of the IL-2 receptor on peripheral blood mononuclear cells. Cell Immunol 136: 62–68
Londei M, Verhoef A, Hawrylowicz C, Groves J, De Berardinis P, Feldmann M (1990): Interleukin 7 is a growth factor for mature human T cells. Eur J Immunol 20: 425–428
Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981): Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T cell growth factor. Cancer Res 41: 4420–4425
Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Kock A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989): IFN-ß2/IL-6 augments the activity of human natural killer cells. J Immunol 143: 1206–1209
Lynch DH, Miller RE (1990): Induction of murine lymphokine-activated killer cells by recombinant IL-7. J Immunol 145: 1983–1990
MacDonald HR, Cerottini J-C, Ryser J-E, Maryanski JL, Taswell C, Widmer MB, Brunner KT (1980): Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev 51: 93–123
Mannel DN, Falk W, Droge W (1983): Induction of cytotoxic T cell function requires sequential action of three different lymphokines. J Immunol 130: 2508–2510
Maraskovsky E, Chen W-F, Shortman K (1989): IL-2 and IFN-y are two necessary lymphokines in the development of cytolytic T cells. J Immunol 143: 1210–1214
Moingeon P, Jitsukawa S, Faure F, Troalen F, Triebel F, Graziani M, Forestier F, Bellet D, Bohuon C, Hercend T (1987): A y-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature 325: 723–726
Morrissey Pi, Goodwin RG, Nordan RP, Anderson D, Grabstein KH, Cosman D, Sims J, Lupton S, Acres B, Reed SG, Mochizuki D, Eisenman J, Conlon PJ, Namen AE (1989): Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 169: 707–716
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986): Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357
Mulé JJ, Smith CA, Rosenberg SA (1987): Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J Exp Med 166: 792–797
Nagler A, Lanier LL, Phillips JH (1988): The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol 141: 2349–2351
Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S, Cosman D, Goodwin RG (1988): Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 6173: 571–573
Noma Y, Sideras P, Naito T, Bergstedt-Lindquist S, Azuma C, Severinson E, Tanabe T, Kinashi T, Matsuda F, Yaoita Y, Honjo T (1986): Cloning of cDNA encoding the murine IgG l induction factor by a novel strategy using SP6 promoter. Nature 319: 640–646
Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T (1988): IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141: 1543–1549
Okazaki H, Ito M, Sudo T, Hattori M, Kano S, Katsura Y, Minato N (1989): IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing aß or yS T-cell receptors in vitro: Synergism with IL-2 J Immunol 143: 2917–2922
Paliard X, Yssel H, Blanchard D, Waitz JA, de Vries JE, Spits H (1989): Antigen-specific and MHC nonrestricted cytotoxicity of T cell receptor aß and;S+ human T cell clones isolated in IL-4. J Immunol 143: 452–457
Paul WE, Ohara J (1987): B-cell stimulatory factor-I/ interleukin 4. Annu Rev Immunol 5: 429–459
Pfeifer JD, McKenzie DT, Swain SL, Dutton RW (1987): B cell stimulatory factor 1 (interleukin-4) is sufficient for the proliferation and differentiation of lectinstimulated cytolytic T lymphocyte precursors. J Exp Med 166: 1464–1470
Plate JMD (1976): Soluble factors substitute for T-T-cell collaboration in generation of T-killer lymphocytes. Nature 260: 329–331
Raulet DH, Bevan MJ (1982): A differentiation factor required for the expression of cytotoxic T-cell function. Nature 296: 754–757
Rosenberg SA, Lotze MT (1986): Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol 4: 681–709
Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (1989): Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210: 474–484
Rosenberg SA, Speiss P, Lafreniere R (1986): A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318–1321
Ryser J-E, Cerottini JC, Brunner KT (1978): Generation of cytolytic T lymphocytes in vitro. IX. Induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J Immunol 120: 370–377
Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991): Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621–624
Simon MM, Hochgeschwender U, Brugger U, Landolfo S (1986): Monoclonal antibodies to interferon-y inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J Immunol 136: 2755–2762
Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE (1988): IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol 141: 29–36
Stotter H, Custer MC, Bolton, ES, Guedez L, Lotze MT (1991): IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J Immunol 146: 150–155
Swisher SG, Economou JS, Carmack Holmes E, Golub SH (1990): TNF-a and IFN-y reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell Immunol 128: 450–461
Takai Y, Herrmann SH, Greenstein JL, Spitainy GL, Burakoff SJ (1986): Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. J Immunol 137: 3494–3500
Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH (1988): B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140: 508–512
Wagner H, Hardt C, Rouse BT, Rollinghoff M, Scheurich P, Pfizenmaier K (1982): Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. J Exp Med 155: 1876–1881
Watson JD, Morrissey PJ, Namen AE, Conlon PJ, Widmer MB (1989): Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol 143: 1215–1222
Widmer MB, Grabstein KH (1987): Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 326: 795–798
Widmer MB, Acres RB, Sassenfeld HM, Grabstein KH (1987): Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4). J Exp Med 166: 1447–1455
Widmer MB, Morrissey PJ, Namen AE, Voice RF, Watson JD (1990): Interleukin 7 stimulates growth of fetal thymic precursors of cytolytic cells: Induction of effector function by interleukin 2 and inhibition by interleukin 4. Int Immunol 2: 1055–1061
Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B (1991): Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146: 3074–3081
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Birkhäuser Boston
About this chapter
Cite this chapter
Alderson, M.R., Widmer, M.B. (1993). Regulatory Effects of Cytokines on the Generation of CTL and LAK Cells. In: Sitkovsky, M.V., Henkart, P.A. (eds) Cytotoxic Cells: Recognition, Effector Function, Generation, and Methods. Birkhäuser Boston. https://doi.org/10.1007/978-1-4684-6814-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6814-4_11
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4684-6816-8
Online ISBN: 978-1-4684-6814-4
eBook Packages: Springer Book Archive